{"id":1365,"date":"2026-04-28T11:46:22","date_gmt":"2026-04-28T09:46:22","guid":{"rendered":"https:\/\/afgenese.com\/af-genese-med\/"},"modified":"2026-06-16T11:49:49","modified_gmt":"2026-06-16T09:49:49","slug":"af-genese-med","status":"publish","type":"page","link":"https:\/\/afgenese.com\/en\/af-genese-med\/","title":{"rendered":"AF GENESE Med"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\r\n\t\t\t\t\r\n\t\t\t\t\tA therapeutic innovation for dystonic motor disorders related to Parkinson's disease\r\n\t\t\t\t\r\n\t\t\t\t<\/h2>\r\n\t\t\t

\r\n\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t\tA.F. GENESE Med: Redefining mobility in Parkinson's disease \r\n\t\t\t\t\r\n\t\t\t\t<\/h4>\r\n\t\t\t
The A.F. GENESE Med program represents the culmination of our commitment to research. This therapeutic innovation project specifically targets one of the most disabling symptoms for patients with Parkinson's disease: dystonic motor disorders. \n<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\r\n\t\t\t\t\r\n\t\t\t\t\tThe challenge: beyond tremor\r\n\t\t\t\t\r\n\t\t\t\t<\/h2>\r\n\t\t\t
While Parkinson's disease is often associated with resting tremor, dystonic disorders\u2014characterized by involuntary, prolonged, and often painful muscle contractions\u2014profoundly impair patients' quality of life and autonomy. These symptoms sometimes resist conventional treatments, creating a major unmet medical need. <\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\r\n\t\t\t
\r\n\t\t\t\t
\r\n\t\t\t

\r\n\t\t\t\t\r\n\t\t\t\t\tOur therapeutic innovation\r\n\t\t\t\t\r\n\t\t\t\t<\/h2>\r\n\t\t\t

\r\n\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t\tA.F. GENESE MED is based on a disruptive approach to neurological modulation\r\n\t\t\t\t\r\n\t\t\t\t<\/h4>\r\n\t\t\t<\/div>\t\t<\/div>\r\n\r\n\t\t
\r\n\t\t\t
\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\tRegulation\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<\/h2>\r\n\t\t\t\t\t\t\t\t\t\t
Regulate the neural signals responsible for abnormal muscle contractions<\/div>\t\t<\/div>\r\n\t\t\r\n\t\t
\t\t\t<\/svg>\r\n\t\t\t<\/div><\/div>\t<\/div>\r\n\t\t
01<\/div><\/div><\/div><\/div> \t\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/article>
\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\tReduction\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<\/h2>\r\n\t\t\t\t\t\t\t\t\t\t
Reduce the impact of dyskinesias (involuntary movements) induced by long-term dopaminergic treatments<\/div>\t\t<\/div>\r\n\t\t\r\n\t\t
\t\t\t<\/svg>\r\n\t\t\t<\/div><\/div>\t<\/div>\r\n\t\t
02<\/div><\/div><\/div><\/div> \t\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/article>
\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\tRestoration\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<\/h2>\r\n\t\t\t\t\t\t\t\t\t\t
Restore movement fluidity by acting on synaptic plasticity<\/div>\t\t<\/div>\r\n\t\t\r\n\t\t
\t\t\t<\/svg>\r\n\t\t\t<\/div><\/div>\t<\/div>\r\n\t\t
03<\/div><\/div><\/div><\/div> \t\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/article>\t\t<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\r\n\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t\tA.F. GENESE technology bridges the most rigorous fundamental research and the concrete daily needs of patients and users.\n\r\n\t\t\t\t\r\n\t\t\t\t<\/h4>\r\n\t\t\t
\n<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\r\n\t\t\t\t\r\n\t\t\t\t\tToward a Pivotal Clinical Phase\n\r\n\t\t\t\t\r\n\t\t\t\t<\/h2>\r\n\t\t\t
The A.F. GENESE Med project is currently entering a pivotal phase of its development.
In collaboration with the Brain and Mind biocluster, we are consolidating evidence of efficacy to provide a concrete and safe therapeutic response to the thousands of people affected by these motor disorders.<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\r\n\t\t\t
\r\n\t\t\t\t\r\n\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t
<\/div>\t\t\t\t<\/div>\r\n\t\t\t\t\t\t
<\/div>\r\n\t\t\t
\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2025<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

E-Tonus<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

E-Tonus is an innovative wellness device, developed and manufactured in France by A.F. GENESE.\nBased on its exclusive and patented technology, the device has already gained more than 300 daily users since its launch in July 2025.\nThis real-world success constitutes major proof of concept, enabling A.F. GENESE to establish the clinical and technological foundations for its future medical device.<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2025<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"E-Tonus\"<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2026<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

Pilot Study<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

Evaluation of the efficacy of E-Tonus in dystonia associated with Parkinson's disease: a multicenter, randomized, double-blind, placebo-controlled trial.<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2026<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"Pilot<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2027<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

A.F. GENESE Med<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

Design and prototyping in compliance with ISO 13485 standard requirements.<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2027<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"A.F.<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2028<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

Pivotal Study<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

Evaluation of the efficacy and safety of A.F. GENESE Med in the treatment of dystonias associated with Parkinson's disease: a multicenter, randomized, double-blind, placebo-controlled trial.<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2028<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"Pivotal<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2029<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

CE Class IIa Certification<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

French market launch<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2029<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"CE<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2030<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

Commercial expansion<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

EU market<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2030<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"Commercial<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t2031<\/span>\r\n\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t

FDA Approval<\/h4>\r\n\t\t\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\t\t

FDA 510(k) \/ De Novo
US market launch<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t

\r\n\t\t\t\t\t\t\t\t\t\t2031<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\"FDA<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t
<\/div>\r\n\t\t\t<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

A therapeutic innovation for dystonic motor disorders related to Parkinson’s disease A.F. GENESE Med: Redefining mobility in Parkinson’s disease The A.F. GENESE Med program represents the culmination of our commitment to research. This therapeutic innovation project specifically targets one of the most disabling symptoms for patients with Parkinson’s disease: dystonic motor disorders. The challenge: beyond […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-1365","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nAF GENESE Med - A. F. Genese<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/afgenese.com\/en\/af-genese-med\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AF GENESE Med - A. F. Genese\" \/>\n<meta property=\"og:description\" content=\"A therapeutic innovation for dystonic motor disorders related to Parkinson’s disease A.F. GENESE Med: Redefining mobility in Parkinson’s disease The A.F. GENESE Med program represents the culmination of our commitment to research. This therapeutic innovation project specifically targets one of the most disabling symptoms for patients with Parkinson’s disease: dystonic motor disorders. The challenge: beyond […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/afgenese.com\/en\/af-genese-med\/\" \/>\n<meta property=\"og:site_name\" content=\"A. F. Genese\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T09:49:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/linkedin.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2501\" \/>\n\t<meta property=\"og:image:height\" content=\"2501\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/\",\"url\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/\",\"name\":\"AF GENESE Med - A. F. Genese\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afgenese.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/linkedin.png\",\"datePublished\":\"2026-04-28T09:46:22+00:00\",\"dateModified\":\"2026-06-16T09:49:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/#primaryimage\",\"url\":\"https:\\\/\\\/afgenese.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/linkedin.png\",\"contentUrl\":\"https:\\\/\\\/afgenese.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/linkedin.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/af-genese-med\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/afgenese.com\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AF GENESE Med\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/afgenese.com\\\/en\\\/\",\"name\":\"A. F. Genese\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/afgenese.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#organization\",\"name\":\"A. F. Genese\",\"url\":\"https:\\\/\\\/afgenese.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/afgenese.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo-AF-GENESE-scaled.png\",\"contentUrl\":\"https:\\\/\\\/afgenese.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo-AF-GENESE-scaled.png\",\"width\":2560,\"height\":717,\"caption\":\"A. F. Genese\"},\"image\":{\"@id\":\"https:\\\/\\\/afgenese.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AF GENESE Med - A. F. Genese","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/afgenese.com\/en\/af-genese-med\/","og_locale":"en_US","og_type":"article","og_title":"AF GENESE Med - A. F. Genese","og_description":"A therapeutic innovation for dystonic motor disorders related to Parkinson’s disease A.F. GENESE Med: Redefining mobility in Parkinson’s disease The A.F. GENESE Med program represents the culmination of our commitment to research. This therapeutic innovation project specifically targets one of the most disabling symptoms for patients with Parkinson’s disease: dystonic motor disorders. The challenge: beyond […]","og_url":"https:\/\/afgenese.com\/en\/af-genese-med\/","og_site_name":"A. F. Genese","article_modified_time":"2026-06-16T09:49:49+00:00","og_image":[{"width":2501,"height":2501,"url":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/linkedin.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/afgenese.com\/en\/af-genese-med\/","url":"https:\/\/afgenese.com\/en\/af-genese-med\/","name":"AF GENESE Med - A. F. Genese","isPartOf":{"@id":"https:\/\/afgenese.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/afgenese.com\/en\/af-genese-med\/#primaryimage"},"image":{"@id":"https:\/\/afgenese.com\/en\/af-genese-med\/#primaryimage"},"thumbnailUrl":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/linkedin.png","datePublished":"2026-04-28T09:46:22+00:00","dateModified":"2026-06-16T09:49:49+00:00","breadcrumb":{"@id":"https:\/\/afgenese.com\/en\/af-genese-med\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/afgenese.com\/en\/af-genese-med\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/afgenese.com\/en\/af-genese-med\/#primaryimage","url":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/linkedin.png","contentUrl":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/linkedin.png"},{"@type":"BreadcrumbList","@id":"https:\/\/afgenese.com\/en\/af-genese-med\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/afgenese.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"AF GENESE Med"}]},{"@type":"WebSite","@id":"https:\/\/afgenese.com\/en\/#website","url":"https:\/\/afgenese.com\/en\/","name":"A. F. Genese","description":"","publisher":{"@id":"https:\/\/afgenese.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/afgenese.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/afgenese.com\/en\/#organization","name":"A. F. Genese","url":"https:\/\/afgenese.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/afgenese.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/logo-AF-GENESE-scaled.png","contentUrl":"https:\/\/afgenese.com\/wp-content\/uploads\/2026\/04\/logo-AF-GENESE-scaled.png","width":2560,"height":717,"caption":"A. F. Genese"},"image":{"@id":"https:\/\/afgenese.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/pages\/1365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/comments?post=1365"}],"version-history":[{"count":4,"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/pages\/1365\/revisions"}],"predecessor-version":[{"id":1472,"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/pages\/1365\/revisions\/1472"}],"wp:attachment":[{"href":"https:\/\/afgenese.com\/en\/wp-json\/wp\/v2\/media?parent=1365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}